Robert DiFazio, Parallel Bio co-founder and CEO, and Juliana Hilliard, co-founder and CSO (Credit: Parallel Bio)
Exclusive: Organoid startup raises $21M to test drugs and vaccines in human lymph nodes-in-a-dish
Parallel Bio, a startup that figured out how to grow miniature human lymph nodes in a dish, has raised $21 million in Series A funding …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
